Notice to Administratively Impose a Matching Requirement, 61655-61656 [E7-21344]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 210 / Wednesday, October 31, 2007 / Notices
Dated: October 25, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–21423 Filed 10–30–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Fees for Sanitation Inspections of
Cruise Ships [Correction]
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice Correction.
AGENCY:
address should read as follows:
Jfa0@cdc.gov
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Jaret
Ames, Chief, Vessel Sanitation Program,
National Center for Environmental
Health, Centers for Disease Control and
Prevention (CDC), 4770 Buford
Highway, NE., Mailstop F–23, Atlanta,
Georgia 30341–3724, telephone (770)
488–3139, E-mail: jfa0@cdc.gov.
Administration for Children and
Families
FOR FURTHER INFORMATION CONTACT:
Dated: October 24, 2007.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. E7–21398 Filed 10–30–07; 8:45 am]
BILLING CODE 4163–18–P
SUMMARY: Correction: This notice was
published in the Federal Register on
October 4, 2007, Volume 72, Number
192, page 56768. The contact e-mail
ACF program office
Program title
CFDA No.
Office of Child Support
Enforcement.
Child Support Enforcement Research.
93.564
Administration for Children, Youth and Families/Children’s Bureau.
Promoting Safe and Stable Families.
Abandoned Infants Assistance.
Child Welfare Service
Training Grants.
Adoption Opportunities ...
Child Abuse and Neglect
Discretionary Activities.
Child Care and Development Block Grant.
93.556
Office of Planning, Research and Evaluation.
rwilkins on PROD1PC63 with NOTICES
VerDate Aug<31>2005
93.575
93.009
PO 00000
Frm 00050
SUMMARY: The Administration for
Children and Families (ACF) hereby
gives notice to the public that certain
programs within the Agency will be
administratively imposing a matching
requirement on grants awarded under
the following program titles and funding
opportunity announcements for Fiscal
Year 2008:
Funding opportunity title
and No.
Amount of
cost share as
% of total
project cost
Section 1115 Demonstration Grants HHS–
2008–ACF–OCSE–
FC–0006.
Multiple Program Announcements.
5
Acceptable types nonfederal resources
10
Cash is preferred and InKind resources from
public entities only are
accepted.
Cash and In-Kind.
20
Cash and In-Kind.
5
Cash and In-Kind.
20
Cash and In-Kind.
93.652
93.670
Compassion Capital
Fund (CCF).
Jkt 214001
Division of Grants Policy,
Office of Financial Services, Office of
Administration, Administration for
Children and Families (ACF),
Department of Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
93.648
93.558
17:45 Oct 30, 2007
Notice to Administratively Impose a
Matching Requirement
93.551
Temporary Assistance for
Needy Families.
Office of Community
Services.
61655
Fmt 4703
Child Care Policy Research Grants HHS–
2008–ACF–OPRE–
YE–0013.
Child Care State Research Capacity Cooperative Agreements
HHS–2008–ACF–
OPRE–YE–0031.
Federal-State Partnerships to Build Capacity
in the Use of TANF
and Related Administrative Data HHS–
2008–ACF–OPRE–
PD–0059.
Intermediary Demonstration Program HHS–
2008–ACF–OCS–EJ–
0035.
Sfmt 4703
E:\FR\FM\31OCN1.SGM
31OCN1
61656
Federal Register / Vol. 72, No. 210 / Wednesday, October 31, 2007 / Notices
ACF program office
Administration on Developmental Disabilities.
Program title
Developmental Disabilities Projects of National Significance.
Historically, ACF has found that the
imposition of a matching requirement
on awards under these programs results
in an increased level of community
support and, often, a higher profile in
the community. This can contribute to
the success and sustainability of the
project. The Fiscal Year 2008 funding
opportunity announcements for each
listed program will advise applicants on
the percentage of funds that must be
contributed through non-Federal
resources, the composition of the match,
and the merit of the match as a criterion
in the competitive review. The amount
and acceptable types of non-Federal
resources allowed is not negotiable.
However, matching may be provided as
direct or indirect costs. The presence
and composition of matching funds may
be used as a criterion in evaluating the
merits of an application during
competitive review. Specific
information related to the matching
requirement and competitive review
will be provided in the specific funding
opportunity announcement. Unmatched
Federal funds will be disallowed. Costs
borne by matching contributions are
subject to the rules governing
allowability found under 45 CFR 74.23
and 45 CFR 92.24.
FOR FURTHER INFORMATION CONTACT:
rwilkins on PROD1PC63 with NOTICES
Melody Wayland, Office of
Administration, Office of Financial
Services Division of Grants Policy, 370
L’Enfant Promenade, SW., 6th Floor
East, Washington, DC 20447, or by
telephone at 202–401–5714 or
mwayland@acf.hhs.gov.
Dated: October 24, 2007.
Curtis L. Coy,
Deputy Assistant Secretary for
Administration, Administration for Children
and Families.
[FR Doc. E7–21344 Filed 10–30–07; 8:45 am]
BILLING CODE 4184–01–P
VerDate Aug<31>2005
CFDA No.
17:45 Oct 30, 2007
Jkt 214001
93.631
Funding opportunity title
and No.
Family Support 360
HHS–2008–ACF–
ADD–DN–0009.
Projects for Youth Information, Training and
Resource Centers for
Youth and Emerging
Leaders with Developmental Disabilities
HHS–2008–ACF–
ADD–DN–0018.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004D–0484]
Guidance for Industry on the Role of
Human Immunodeficiency Virus
Resistance Testing in Antiretroviral
Drug Development; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a guidance for industry
entitled ‘‘Role of HIV Resistance Testing
in Antiretroviral Drug Development.’’
This guidance is intended to assist
sponsors in the clinical development of
drugs for the treatment of human
immunodeficiency virus (HIV)
infection. Specifically, this guidance
addresses the agency’s current thinking
regarding the role of HIV resistance
testing during antiretroviral drug
development and postmarketing. This
guidance discusses important
nonclinical studies that are
recommended before the initiation of
phase 1 clinical studies in HIV-infected
patients. In addition, this guidance
addresses the use of resistance testing in
clinical phases of drug development and
recommends the type of information
that should be collected and the types
of analyses that should be conducted to
characterize an antiretroviral’s
resistance profile. This guidance
finalizes the draft guidance published
on November 29, 2004.
DATES: Submit written or electronic
comments on agency guidances at any
time.
ADDRESSES: Submit written requests for
single copies of this guidance to the
Division of Drug Information (HFD–
240), Center for Drug Evaluation and
Research, Food and Drug
Administration, 5600 Fishers Lane,
PO 00000
Frm 00051
Fmt 4703
Amount of
cost share as
% of total
project cost
Sfmt 4703
25
Acceptable types nonfederal resources
Cash and In-Kind.
Rockville, MD 20857. Send one selfaddressed adhesive label to assist that
office in processing your requests.
Submit written comments on the
guidance to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.fda.gov/dockets/ecomments or
https://www.regulations.gov. See the
SUPPLEMENTARY INFORMATION section for
electronic access to the guidance
document.
FOR FURTHER INFORMATION CONTACT:
Jeffrey Murray, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, rm. 6360,
Silver Spring, MD 20993–0002, 301–
796–1500, or
Kimberly Struble, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, rm. 6374,
Silver Spring, MD 20993–0002, 301–
796–1500.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a guidance for industry entitled ‘‘Role of
HIV Resistance Testing in Antiretroviral
Drug Development.’’ This guidance is
intended to assist sponsors in the
clinical development of drugs for the
treatment of HIV infection. Specifically,
this guidance addresses the agency’s
current thinking regarding the role of
HIV resistance testing during
antiretroviral drug development and
postmarketing. This guidance discusses
the nonclinical studies (mechanism of
action, antiviral activity in vitro, the
effects of serum protein binding on
antiviral activity, cytotoxicity and
therapeutic index, and in vitro
combination activity) that should be
completed before the initiation of phase
1 clinical studies in HIV-infected
patients. In addition, this guidance
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 72, Number 210 (Wednesday, October 31, 2007)]
[Notices]
[Pages 61655-61656]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-21344]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Notice to Administratively Impose a Matching Requirement
AGENCY: Division of Grants Policy, Office of Financial Services, Office
of Administration, Administration for Children and Families (ACF),
Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families (ACF) hereby
gives notice to the public that certain programs within the Agency will
be administratively imposing a matching requirement on grants awarded
under the following program titles and funding opportunity
announcements for Fiscal Year 2008:
----------------------------------------------------------------------------------------------------------------
Amount of cost Acceptable
Funding share as % of types non-
ACF program office Program title CFDA No. opportunity total project federal
title and No. cost resources
----------------------------------------------------------------------------------------------------------------
Office of Child Support Child Support 93.564 Section 1115 5 Cash is
Enforcement. Enforcement Demonstration preferred and
Research. Grants HHS- In-Kind
2008-ACF-OCSE- resources from
FC-0006. public
entities only
are accepted.
Administration for Children, Promoting Safe 93.556 Multiple 10 Cash and In-
Youth and Families/ and Stable .............. Program Kind.
Children's Bureau. Families. 93.551 Announcements.
Abandoned ..............
Infants 93.648
Assistance.
Child Welfare
Service
Training
Grants.
Adoption 93.652
Opportunities.
Child Abuse and 93.670
Neglect
Discretionary
Activities.
Office of Planning, Research Child Care and 93.575 Child Care 20 Cash and In-
and Evaluation. Development Policy Kind.
Block Grant. Research
Grants HHS-
2008-ACF-OPRE-
YE-0013.
Child Care
State Research
Capacity
Cooperative
Agreements HHS-
2008-ACF-OPRE-
YE-0031..
Temporary 93.558 Federal-State 5 Cash and In-
Assistance for Partnerships Kind.
Needy Families. to Build
Capacity in
the Use of
TANF and
Related
Administrative
Data HHS-2008-
ACF-OPRE-PD-00
59.
Office of Community Services. Compassion 93.009 Intermediary 20 Cash and In-
Capital Fund Demonstration Kind.
(CCF). Program HHS-
2008-ACF-OCS-E
J-0035.
[[Page 61656]]
Administration on Developmental 93.631 Family Support 25 Cash and In-
Developmental Disabilities. Disabilities 360 HHS-2008- Kind.
Projects of ACF-ADD-DN-000
National 9.
Significance. Projects for
Youth
Information,
Training and
Resource
Centers for
Youth and
Emerging
Leaders with
Developmental
Disabilities
HHS-2008-ACF-A
DD-DN-0018..
----------------------------------------------------------------------------------------------------------------
Historically, ACF has found that the imposition of a matching
requirement on awards under these programs results in an increased
level of community support and, often, a higher profile in the
community. This can contribute to the success and sustainability of the
project. The Fiscal Year 2008 funding opportunity announcements for
each listed program will advise applicants on the percentage of funds
that must be contributed through non-Federal resources, the composition
of the match, and the merit of the match as a criterion in the
competitive review. The amount and acceptable types of non-Federal
resources allowed is not negotiable. However, matching may be provided
as direct or indirect costs. The presence and composition of matching
funds may be used as a criterion in evaluating the merits of an
application during competitive review. Specific information related to
the matching requirement and competitive review will be provided in the
specific funding opportunity announcement. Unmatched Federal funds will
be disallowed. Costs borne by matching contributions are subject to the
rules governing allowability found under 45 CFR 74.23 and 45 CFR 92.24.
FOR FURTHER INFORMATION CONTACT: Melody Wayland, Office of
Administration, Office of Financial Services Division of Grants Policy,
370 L'Enfant Promenade, SW., 6th Floor East, Washington, DC 20447, or
by telephone at 202-401-5714 or mwayland@acf.hhs.gov.
Dated: October 24, 2007.
Curtis L. Coy,
Deputy Assistant Secretary for Administration, Administration for
Children and Families.
[FR Doc. E7-21344 Filed 10-30-07; 8:45 am]
BILLING CODE 4184-01-P
